Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
David R. Booth(Hammersmith Hospital), Mark B. Pepys(University College London), Philip N. Hawkins(The Royal Free Hospital), Margaret Sunde(The University of Sydney), Vittorio Bellotti(University of Pavia), Sheena E. Radford(University of Leeds), Christopher M. Dobson(University of Cambridge), Colin Blake(University of Oxford), Carol V. Robinson(Center for NanoScience), Winston L. Hutchinson(Hammersmith Hospital), Paul E. Fraser(University of Toronto)
Cited by 1,044
Related Papers
Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis
|New England Journal of Medicine|2018|2.9k
Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis
|Circulation|2016|2k
NALP3 Forms an IL-1β-Processing Inflammasome with Increased Activity in Muckle-Wells Autoinflammatory Disorder
|Immunity|2004|1.7k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
An Analytical Solution to the Kinetics of Breakable Filament Assembly
|Science|2009|1.1k